World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
140
Citations
62363
World Ranking
55
National Ranking
27

Medicine

D-Index
143
Citations
65603
World Ranking
1524
National Ranking
885

Douglas R. Lowy publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Douglas R. Lowy sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 381 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Douglas R. Lowy D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas R. Lowy sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 140 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 2018 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)
  • 2011 - Albert B. Sabin Gold Medal, Sabin Vaccine Institute
  • 2009 - Member of the National Academy of Sciences
  • 2003 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Douglas R. Lowy is affiliated with the National Institutes of Health in the United States. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology, with a notable emphasis on Epidemiology, Molecular Biology, Infectious Diseases, Oncology, and Cancer Research.

Their main research topics include:

  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • Bioinformatics and Genomic Networks
  • Global Cancer Incidence and Screening

Douglas R. Lowy's recent papers cover a range of critical subjects in medicine and cancer research. Notable publications include:

  • "The Effect of Advances in Lung-Cancer Treatment on Population Mortality," 2020, published in New England Journal of Medicine
  • "Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection," 2021, published in JAMA Internal Medicine
  • "Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial," 2020, published in JNCI Journal of the National Cancer Institute
  • "The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment," 2021, published in Cell
  • "An Introduction to Virus Infections and Human Cancer," 2020, published in Recent Results in Cancer Research

Frequent co-authors in their research include:

  • John T. Schiller
  • Carolina Porras
  • Aimée R. Kreimer
  • Rolando Herrero
  • Xiaolan Qian

Their work has been regularly published in journals such as:

  • Cancer Research
  • JNCI Journal of the National Cancer Institute
  • Zenodo (CERN European Organization for Nuclear Research)
  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines

Douglas R. Lowy has received several honors including the Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research (2018), the Albert B. Sabin Gold Medal from the Sabin Vaccine Institute (2011), membership in the National Academy of Sciences (2009), the National Academy of Medicine (2003), and the Association of American Physicians.

Best Publications

  • Mechanism of activation of a human oncogene.

    Clifford J. Tabin;Scott M. Bradley;Cornelia I. Bargmann;Robert A. Weinberg

  • Toward a Shared Vision for Cancer Genomic Data.

    Robert L. Grossman;Allison P. Heath;Vincent Ferretti;Harold E. Varmus

  • Function and regulation of ras.

    Douglas R. Lowy;Berthe M. Willumsen

  • The Effect of Advances in Lung-Cancer Treatment on Population Mortality

    Nadia Howlader;Gonçalo Forjaz;Meghan J. Mooradian;Rafael Meza

  • Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

    R Kirnbauer;F Booy;N Cheng;D R Lowy

  • HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

    P. Hawley-Nelson;K.H. Vousden;N.L. Hubbert;D.R. Lowy

  • The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes

    Ronald W. Ellis;Deborah DeFeo;Thomas Y. Shih;Matthew A. Gonda

  • Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

    Reinhard Kirnbauer;Janet Taub;Heather Greenstone;Richard Roden

  • Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

    Allan Hildesheim;Rolando Herrero;Sholom Wacholder;Ana C. Rodriguez

  • Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine

    Clayton D. Harro;Yuk Ying Susana Pang;Richard B.S. Roden;Allan Hildesheim

  • Murine Leukemia Virus: High-Frequency Activation in vitro by 5-Iododeoxyuridine and 5-Bromodeoxyuridine

    D. R. Lowy;W. P. Rowe;N. Teich;J. W. Hartley

  • Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus

    Esther H. Chang;Esther H. Chang;Mark E. Furth;Edward M. Scolnick;Douglas R. Lowy

  • The p21 ras C-terminus is required for transformation and membrane association

    Berthe M. Willumsen;Annette Christensen;Nancy L. Hubbert;Alex G. Papageorge

  • Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

    F Breitburd;R Kirnbauer;N L Hubbert;B Nonnenmacher

  • Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

    Jeffrey E. DeClue;Alex G. Papageorge;Jonathan A. Fletcher;Scott R. Diehl

  • Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.

    Hedy Adari;Douglas R. Lowy;Berthe M. Willumsen;Channing J. Der

  • Prophylactic human papillomavirus vaccines

    Douglas R. Lowy;John T. Schiller

  • Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

    Jeffrey N Roberts;Christopher B Buck;Cynthia D Thompson;Rhonda Kines

  • HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

    Maura L. Gillison;Anil K. Chaturvedi;Douglas R. Lowy

  • Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

    Thierry J. Velu;Laura Beguinot;William C. Vass;Mark C. Willingham

  • Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

    Allan Hildesheim;Rolando Herrero;Sholom Wacholder;Ana C. Rodriguez

Frequent Co-Authors

John T. Schiller
John T. Schiller National Institutes of Health
Allan Hildesheim
Allan Hildesheim National Institutes of Health
William C. Vass
William C. Vass National Institutes of Health
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Edward M. Scolnick
Edward M. Scolnick Broad Institute
Ligia A. Pinto
Ligia A. Pinto Leidos (United States)
Mark Schiffman
Mark Schiffman National Institutes of Health
Richard B.S. Roden
Richard B.S. Roden Johns Hopkins University
Christopher B. Buck
Christopher B. Buck National Institutes of Health
Sholom Wacholder
Sholom Wacholder National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their studies beyond microbiology, several related online degrees offer flexible learning options. Prospective students can explore opportunities like what medical degrees can I get online, which include fields complementary to microbiology such as healthcare administration and public health.

Public health is a particularly accessible option, with numerous universities offering easy MPH online programs for students seeking a streamlined admission process. These programs provide valuable skills in epidemiology and disease control, closely aligned with microbiology.

Graduates may also consider career pathways that involve direct application of their knowledge, such as becoming a child life specialist. Understanding the role and compensation is essential, and insights can be found in resources like how much do child life specialists make.

Accessibility is key for many learners, and it's encouraging to see options available for all backgrounds. Those with challenging pasts can find guidance on degrees felons can get, helping to open doors for a fresh start in the sciences or healthcare fields.

Best Scientists Citing Douglas R. Lowy

Trending Scientists

Recently Published Articles